Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 102Carcinoma, Intraductal, Noninfiltrating 12Breast Carcinoma In Situ 10Ovarian Neoplasms 6Neoplasm Metastasis 6Breast Neoplasms, Male 6Neoplasms 5Glioblastoma 5Central Nervous System Neoplasms 5Prostatic Neoplasms 4Gliosarcoma 4Inflammatory Breast Neoplasms 3Glioma 3Brain Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Oligodendroglioma 2Glioma, Subependymal 2Fallopian Tube Neoplasms 2Ependymoma 2Breast Cancer Female 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Sarcoma 1Risk Reduction Behavior 1

Interventions

Cyclophosphamide 22Paclitaxel 12Epirubicin 12Doxorubicin 11Trastuzumab 10Docetaxel 10Carboplatin 10Taxes 7Bevacizumab 6pembrolizumab 5Radiotherapy 5Filgrastim 5Albumin-Bound Paclitaxel 5Neoadjuvant Therapy 4130-nm albumin-bound paclitaxel 4Thiotepa 3Tamoxifen 3Panitumumab 3Melphalan 3Lapatinib 3Granulocyte Colony-Stimulating Factor 3Fluorouracil 3Chemotherapy, Adjuvant 3sargramostim 2pertuzumab 2eribulin 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Cisplatin 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Inflammatory Breast Neoplasms × Tamoxifen × Clear all
NCT00003042 2026-02-20

Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer

City of Hope Medical Center

Phase 2 Completed
41 enrolled 9 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003199 2017-07-12

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Fred Hutchinson Cancer Center

Phase 2 Completed
50 enrolled 11 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male, Inflammatory Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

National Cancer Institute (NCI)

Phase 2 Unknown
94 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡